Aeon Biopharma Inc. (AEON) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Aeon Biopharma Inc. (AEON:NYSE), powered by AI.

Current Price
$0.67
Sector
Healthcare
What is the Aeon Biopharma Inc. stock price forecast?

Aeon Biopharma Inc. is currently trading at $0.67. View real-time AI analysis on Alpha Lenz.

What is Aeon Biopharma Inc. insider trading activity?

View the latest insider trading data for Aeon Biopharma Inc. on Alpha Lenz.

What is Aeon Biopharma Inc.'s P/E ratio?

View Aeon Biopharma Inc.'s valuation metrics on Alpha Lenz.

Aeon Biopharma Inc.

NYSE · AEON
$0.67+0.01(+0.81%)Pre-marketNYSE regular session 09:30–16:00 ET
Ask about Aeon Biopharma Inc.'s future dividend policy...
Alpha Chat Insight

Aeon Biopharma Inc.'s ROE is 93.8%. Explore profitability and growth together.

Ask for details

Company Overview

Aeon Biopharma Inc. is a biopharmaceutical company focusing on the development and commercialization of therapeutic treatments across a broad spectrum of medical conditions. Its primary mission is to leverage innovative biotechnological advancements to improve patient outcomes, particularly in the realm of neurology and other chronic and debilitating disorders. Aeon Biopharma places significant emphasis on research and development, seeking to introduce novel therapies that can transform standard care practices. Operating within the dynamic pharmaceutical sector, the company has an impact on healthcare providers, regulatory bodies, and patients by advancing medical solutions that could potentially alleviate conditions previously thought to be untreatable. As an integral part of the biotechnology industry, Aeon Biopharma Inc. contributes to the broader medical innovation landscape, aiming to meet the growing demands for effective medical interventions by employing cutting-edge research methodologies and strategic partnerships.

CEOMr. Robert Bancroft
SectorHealthcare
IndustryBiotechnology
Employees5

Company Statistics

FY 2025

Profile

N/AMarket Cap
$0.00Revenue
0.00Shares Out
5Employees

Margins

N/AGross
N/AEBITDA
N/AOperating
N/APre-Tax
N/ANet

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

N/ARev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-901.45%ROA
93.84%ROE
-374.67%ROIC

Financial Health

$3.01MCash & Cash Equivalents
$57.58MNet Debt
-110.10%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Aeon Biopharma Inc. (ticker: AEON) is a company listed on NYSE in the Healthcare sector (Biotechnology). It has approximately 5 employees.

The current price is $0.67 with a P/E ratio of -x and P/B of -x.

ROE is 93.84%.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Aeon Biopharma Inc. (AEON) Stock Forecast 2026 $0.67 — Price, Financials & Analyst Targets | Alpha Lenz